KLRB1 and in situ carcinoma: Although the percentage of FrII activated Treg was similar between the CIS and HC groups, greater proportions of FrII Treg with proinflammatory CD161+ Th17- and Th17.1-like phenotypes were detected in CIS (Supplementary Figure S2).